clobazam has been researched along with Morbid Obesity in 1 studies
Clobazam: A benzodiazepine derivative that is a long-acting GABA-A RECEPTOR agonist. It is used as an antiepileptic in the treatment of SEIZURES, including seizures associated with LENNOX-GASTAUT SYNDROME. It is also used as an anxiolytic, for the short-term treatment of acute ANXIETY.
clobazam : 7-Chloro-1H-1,5-benzodiazepine-2,4(3H,5H)-dione in which the hydrogen attached to the nitrogen at position 1 is substituted by a methyl group, whilst that attached to the other nitrogen is substituted by a phenyl group. It is used for the short-term management of acute anxiety and as an adjunct in the treatment of epilepsy in association with other antiepileptics.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augustin, P | 1 |
| Desmard, M | 1 |
| Arapis, K | 1 |
| Fournier, P | 1 |
| Ribeiro-Parenti, L | 1 |
| Montravers, P | 1 |
1 other study available for clobazam and Morbid Obesity
| Article | Year |
|---|---|
Prolonged benzodiazepine coma as a complication of morbid obesity.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Benzodiazepines; Clobazam; Clorazepate Dipotassium | 2013 |